Lanean...
The Aryl Hydrocarbon Receptor (AhR) as a Drug Target for Cancer Chemotherapy
The aryl hydrocarbon receptor (AhR) is overexpressed in some patients with different tumor types, and the receptor can be a negative or positive prognostic factor. There is also evidence from both in vivo and in vitro cell culture models that the AhR can exhibit tumor-specific pro-oncogenic and tumo...
Gorde:
| Argitaratua izan da: | Curr Opin Toxicol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5407490/ https://ncbi.nlm.nih.gov/pubmed/28459113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cotox.2017.01.012 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|